Cystic Fibrosis: Pulmonary Aspects of the Disease

Cystic fibrosis (CF) is a genetic disease which is usually caused by the absence, dysfunction
or reduced number of the multifunctional CF transmembrane regulator (CFTR) protein...
Recently new therapy approaches such as ivacaftor have emerged which target the cause of
the condition itself. This white paper focusses only on the current treatment of pulmonary
complications of CF.

Enter your details below to view the free whitepaper

By downloading this Whitepaper, you acknowledge that Global Data Plc may share your information with our white paper partners/sponsors who may contact you directly with information on their products and services.

Visit our Privacy Policy for more information about our services, how Global Data Plc may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.